Back
Novartis AG Quote, Financials, Valuation and Earnings
Sponsored
NVS
Sponsored
The little-known AI stock you need to read about now...
Get the name - FREE.
Buy
72
NVS
Novartis AG
Last Price:
97.26
Seasonality Move:
2.69%
7 Day Trial
ALL ACCESS PASS
$
7
Election Shock on August 19th?
Click here now to see the evidence I've gathered.Novartis AG Price Quote
$97.26
-0.01 (-0.08%)
(Updated: May 4, 2024 at 6:30 AM ET)
Novartis AG Key Stats
Buy
72
Novartis AG (NVS)
is a Buy
Day range:
$97.07 - $97.91
52-week range:
$92.19 - $108.78
Dividend yield:
3.88%
P/E ratio:
13.70
P/S ratio:
4.04
P/B ratio:
5%
Volume:
1M
Avg. volume:
1.8M
1-year change:
-6.87%
Market cap:
$198.5B
Revenue:
$46.7B
EPS:
$7.33
How Much Does Novartis AG Make?
-
How Much Are Novartis AG's Sales Annually?
NVS Revenues are $46.7B -
How Much Profit Does Novartis AG's Make A Year?
NVS net income is $14.9B
Is Novartis AG Growing As A Company?
-
What Is Novartis AG's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.1% -
What Is Novartis AG's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0.21%
Novartis AG Stock Price Performance
-
Did Novartis AG Stock Go Up Last Month?
Novartis AG share price went up by 3.07% last month -
Did NVS's Share Price Rise Over The Last Year?
NVS share price fell by -6.87% over the past 1 year
What Is Novartis AG 52-Week High & Low?
-
What Is Novartis AG’s 52-Week High Share Price?
Novartis AG has traded as high as $108.78 over the past 52 weeks -
What Is Novartis AG’s 52-Week Low Share Price?
Novartis AG has traded as low as $92.19 over the past 52 weeks
Novartis AG Price To Free Cash Flow
-
Is Novartis AG Stock Overvalued?
Novartis AG is trading at a price to free cash flow ratio of 19.70 -
Is Novartis AG Stock Undervalued?
Novartis AG EV to Free Cash Flow ratio is 20.92 -
What Is Novartis AG’s Price Earnings Growth Ratio?
NVS PEG ratio is 0.11 -
Is Novartis AG Trading At A Premium To Earnings?
Novartis AG EV to EBIT ratio is 20.02
Is It Risky To Buy Novartis AG?
-
How Much Debt Does Novartis AG Have?
Total long term debt quarterly is $25.5B -
How Much Cash Does Novartis AG Have?
Cash and short term investments quarterly total is $9.7B -
What Is Novartis AG’s Book Value Per Share?
Book value per share is 19.44
Is Novartis AG Cash Flow Positive?
-
What Is NVS Cash Flow From Operations?
Cash flow from operations (TTM) is $13.8B -
What Is Novartis AG’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$10.2B -
What Is Novartis AG’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$5.9B
Novartis AG Return On Invested Capital
-
Is Management Doing A Good Job?
NVS return on invested capital is 21.39% -
What Is Novartis AG Return On Assets?
ROA measures how assets are converting to revenues and is 14.38% -
What Is NVS Return On Equity?
ROE is a measure of profitability and is 33.31%
Novartis AG Earnings Date & Stock Price
-
What Is Novartis AG's Stock Price Today?
A single share of NVS can be purchased today for 97.27 -
What Is Novartis AG’s Stock Symbol?
Novartis AG trades on the nyse under the ticker symbol: NVS -
When Is Novartis AG’s Next Earnings Date?
The next quarterly earnings date for Novartis AG is scheduled on July 18, 2024 -
When Is NVS's next ex-dividend date?
Novartis AG's next ex-dividend date is March 7, 2024 -
How To Buy Novartis AG Stock?
You can buy Novartis AG shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Novartis AG Competitors
-
Who Are Novartis AG's Competitors?
Below is a list of companies who compete with Novartis AG or are related in some way:
Novartis AG Dividend Yield
-
What Is NVS Dividend Yield?
Novartis AG’s dividend yield currently is 3.88% -
What Is Novartis AG’s Payout Ratio?
Novartis AG’s payout ratio is 34.16% -
When Did Novartis AG Last Pay A Dividend?
The latest dividend pay date is May 6, 2024 -
What Is Novartis AG’s Dividend Per Share?
Novartis AG pays a dividend of $3.78 per share
Novartis AG Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 21.3% | 6.94% |
Revenue: | 9.71% | 2.88% |
Analyst Recommendations
Buy Recommendations: | 3 |
---|---|
Hold Recommendations: | 7 |
Sell Recommendations: | 0 |
Price Target: | 110.81 |
Upside from Last Price: | 13.92% |